NCT00683410View on ClinicalTrials.gov

Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)

CompletedOBSERVATIONAL
Enrollment

3,366

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Vaccines, Pneumococcal Conjugate Vaccine
Interventions
BIOLOGICAL

Pneumococcal Conjugate Vaccine, 7-valent (Prevenar)

Trial Locations (1)

Unknown

City of Muntinlupa

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00683410 - Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent) | Biotech Hunter | Biotech Hunter